Related by context. All words. (Click for frequent words.) 61 anti fibrotic 59 Nexavar sorafenib 58 GW# [003] 58 sitaxsentan 58 Squalamine 58 mediated inhibition 58 liposomal formulation 58 cathepsin K inhibitor 57 vidofludimus 57 MS relapses 57 Glypromate 57 glucosylceramide 57 VEGF inhibitor 57 preclinically 57 zotarolimus 56 GIPET 56 Aplidin 56 Spiegelmer 56 CBLC# 56 small molecule tyrosine 56 Symadex 56 novel oral anticoagulant 56 ACTOS ® 56 volociximab 56 PF # [002] 56 thalidomide Thalomid 56 JAK#/JAK# 56 indibulin 56 targeting PCSK9 56 Subgroup analysis 55 dasatinib Sprycel 55 Endeavor DES 55 mecamylamine 55 ARIKACE ™ 55 schizophrenia CIAS 55 PEG IFN 55 HyACT 55 EGS# 55 Cand5 55 PSN# [001] 55 Ophena 55 dose dependently 55 preclinical efficacy 55 Fibroblast Growth Factor Receptor 55 fosbretabulin 55 IIa trials 54 AMPK activators 54 BrachySil TM 54 Myelodysplastic Syndrome MDS 54 dorzolamide 54 subcutaneous immunoglobulin 54 FK# 54 delipidation 54 Epigenomics proprietary 54 OvaRex MAb 54 PSMA ADC 54 relapsed MM 54 CytoFabTM 54 DP b# 54 photoprotective drug 54 serum biomarker 54 inhibits VEGF 54 allergic airway inflammation 54 nucleotide analog 54 SUTENT ® 54 CVac 54 selective agonist 54 eluting stent 54 Xanafide 54 2 methoxyestradiol #ME# 54 lenalidomide Revlimid 54 samalizumab 54 bioresorbable stent 54 PEGylated interferon 54 Tesmilifene 53 siRNAs targeting 53 CRLX# 53 cediranib 53 beta 1a 53 effector function 53 Pyridorin 53 Vidaza azacitidine 53 elotuzumab 53 Velcade bortezomib 53 HQK 53 antiangiogenic therapy 53 Toraymyxin TM 53 anti angiogenic agent 53 Fc fusion protein 53 lumiliximab 53 Technosphere ® 53 homocysteine assay 53 pioglitazone HCl 53 antitumor efficacy 53 plasma renin activity 53 BIM #A# 53 PI3K/Akt pathway inhibitor 53 rxRNA 53 PDE4 inhibitor 53 antiangiogenic agent 53 NeuVax 53 imexon 53 Revotar 53 HCV protease inhibitors 53 Dacogen decitabine 53 radiation sensitizer 53 ReN# 53 immunomodulation 53 inhaled AAT 53 Sutent sunitinib 53 everolimus eluting stents 53 sargramostim 53 AERx iDMS 53 receptor antagonism 53 TRIST study 53 ABL1 53 efficacy endpoint 53 triphendiol 53 motesanib diphosphate 53 HDL Selective Delipidation 53 docetaxel Taxotere ® 53 HuMax 53 immunotherapeutic vaccine 53 Olaparib 53 Potelligent Technology 53 HGS# 53 trastuzumab emtansine T DM1 53 GeneICE 53 Fludara ® 53 Tyrima 53 miRview mets 53 radiosensitivity 53 NOD mouse 53 GRN# 53 Orally administered 53 aurora kinase inhibitor 53 RLY# 52 Hectorol R 52 PEGPH# 52 serum lipid 52 Lixivaptan 52 Zevalin consolidation 52 VitroGro 52 target lesion revascularizations 52 oral antiplatelet agent 52 deforolimus 52 sDNA 52 A1PI 52 BAL# [002] 52 vivo potency 52 Cellcept 52 LHRH antagonists 52 genotoxicity 52 ENMD # 52 XmAb 52 mTOR inhibition 52 PTK# 52 K ras mutations 52 carcinoembryonic antigen 52 galectin 3 52 small molecule activators 52 peptide conjugated 52 trodusquemine 52 colorectal adenoma 52 Pharmacokinetic studies 52 Entocort 52 Plicera 52 haematological cancers 52 CA9 SCAN 52 fibrate drugs 52 intracellular uptake 52 bortezomib Velcade 52 PhG alpha 1 52 potency selectivity 52 Talotrexin 52 JAK inhibitors 52 Accordion Pill 52 immune modulating 52 reslizumab 52 signal transduction inhibitor 52 doxorubicin docetaxel 52 regorafenib 52 YONDELIS 52 TriRima 52 prostate cancer CaP 52 antihormonal 52 ANAVEX #-# [001] 52 Pentraxin 2 52 Cipralex ® 52 colorectal carcinoma 52 Cinquil 52 cMET 52 antisense inhibition 52 Teriflunomide 52 AST ALT 52 novel therapeutic antibodies 52 CCR9 antagonist 52 EVIZON ™ 52 IV Busulfex 52 FTIs 52 Sanvar 51 MET inhibitor 51 alagebrium 51 R roscovitine 51 exon skipping 51 cytoreductive nephrectomy 51 peptidomimetic 51 ATL# [001] 51 GDIR 51 SNALP formulations 51 Vascugel ® 51 OvPlex ™ 51 XmAb# 51 serum phosphate levels 51 PDE4 inhibitors 51 BioMatrix TM 51 Aposense 51 thymidylate synthase TS 51 pressure natriuresis 51 myocardial necrosis 51 Epirubicin 51 OvaRex R 51 Discovery Labs KL4 51 MorphoSys proprietary 51 Vidofludimus 51 lymphocyte counts 51 Annamycin 51 biliary tract cancer 51 Liprotamase 51 PI3K/mTOR 51 generation FBPase inhibitor 51 dipyridamole plus 51 THR beta agonist 51 ulimorelin 51 Ziprasidone 51 autoantibody levels 51 gonadotrophin releasing hormone GnRH 51 Optiquel ™ 51 ART# 51 Oxidized LDL 51 histologic subtype 51 QTinno 51 xanthine oxidase inhibitor 51 Gleevec resistant 51 TRX1 51 ZACTIMA 51 PRESEPT study 51 Pitavastatin 51 pretreatment serum 51 selective modulator 51 Omthera 51 Belerofon 51 JAK2 inhibitor 51 REMINYL ® 51 product ColonSentry TM 51 canakinumab 51 Microwave Ablation System 51 Virulizin ® 51 Temsirolimus 51 Alfimeprase 51 myocardial reperfusion 51 ADP receptor antagonist 51 rituximab Rituxan 51 Protease Inhibitors 51 vascular disrupting agent 51 docetaxel Taxotere R 51 antiplatelets 51 HIV integrase inhibitor 51 DCCR 51 Corus CAD 51 oxaliplatin Eloxatin 51 Oncotype DX colon cancer 51 multicenter clinical trials 51 potently inhibits 51 metabonomics 51 Src inhibitors 51 CYP#D# inhibitor 51 INTEGRILIN 51 Galectin 3 51 myocardial infarct size 51 Monoclonal antibody 51 imatinib therapy 51 serum lipid levels 51 Dynabeads 51 bevasiranib 51 tramiprosate Alzhemed TM 51 Nanobody R 51 predialysis 51 Diasome 51 RH1 51 Hemopurifier ® 51 viral titers 51 sitagliptin metformin 51 ® pioglitazone HCl 51 glycosylated hemoglobin levels 50 AERx R 50 Anticalin R 50 Oncotype DX Recurrence Score 50 endothelin receptor antagonists 50 Afatinib 50 p# activation 50 Neuraltus 50 interferon beta therapy 50 isoform selective 50 OvaRex 50 novel immunotherapeutic 50 cardiac allograft vasculopathy 50 SYN X 50 Trophos 50 bioabsorbable polymer 50 irbesartan 50 IPL# 50 introduced NEUGENE 50 hepatic insulin sensitivity 50 peritoneal carcinomatosis 50 GLP toxicology studies 50 TAKSTA 50 mTOR mammalian target 50 IgG1 antibodies 50 MICARDIS ® 50 mCRPC 50 cetilistat 50 recurrent DVT 50 Hedgehog antagonist 50 PORxin TM 50 TAXUS Liberte Stent 50 bioequivalency 50 systemic RNAi 50 LHRH receptor positive 50 aerosolized KL4 surfactant 50 Biomerk Tumorgrafts 50 Interferon beta 50 RhuDex R 50 thyroid carcinoma 50 carotid IMT 50 Xcellerated T Cells 50 active moiety 50 PTHrP 50 CellCiphr 50 CCR5 antagonist 50 papillary renal cell carcinoma 50 APTIVUS R 50 miconazole Lauriad ® 50 ChronVac C R 50 chimeric monoclonal antibody 50 fibrotic disease 50 Injectafer 50 HalcyGen 50 troponin assay 50 nanopharmaceutical 50 synthase TS 50 targeted radiotherapeutic 50 clinical pharmacology studies 50 adenosine deaminase 50 liposome formulation 50 Combination antiretroviral therapy 50 multicenter Phase II 50 inflammatory biomarkers 50 PrevOnco 50 cannabinor 50 enalapril 50 Spiegelmer ® 50 GnRH antagonist 50 Xarelto rivaroxaban 50 homocysteine concentrations 50 NADiA 50 UPLYSO 50 platelet aggregation inhibitor 50 Phase IIa trials 50 Genz # 50 TroVax ® 50 novel VDA molecule 50 echocardiographic parameters 50 XTEN 50 ACOMPLIA R 50 PIGF 50 TriGrid ™ 50 Lipid lowering 50 injectable formulations 50 IV bisphosphonates 50 IMC #B 50 serum phosphate 50 pharmacokinetic equivalence 50 PA8 50 Angioblast 50 TAXUS Express Stent 50 antidepressant efficacy 50 omacetaxine mepesuccinate 50 urinary excretion 50 HCV polymerase inhibitor 50 ThermoDox R 50 nitrotyrosine 50 Vascugel R 50 oxidative stress markers 50 investigational antiplatelet 50 Amikacin Inhale 50 brivaracetam 50 Caris MPI 50 melatonin receptor 50 multitargeted 50 PROLARIS 50 Vascular Wrap TM 50 NP2 50 OMAPRO 50 EndoTAG TM -1 50 myelofibrosis MF 50 RezularTM 50 HepaSphere 50 UVIDEM 50 extracellular dopamine 50 Sygnis 50 LB# [003] 50 immatics 50 Davanat 50 DUROS 50 glucokinase activator 50 CIMZIA ™ 50 Losartan 50 vascular disrupting agents 50 Ph3 50 GPC3 50 Trofex 50 vivo preclinical 50 ABSORB trial 50 topical ophthalmic 50 Oasmia 50 Phase 1a clinical 50 antithrombotic 50 kinase profiling 50 recurrent NSCLC 50 Alvesco R 50 lactate dehydrogenase 50 Vernakalant 50 Glatiramer acetate 49 papillary RCC 49 Vectibix monotherapy 49 Teijin Pharma 49 baseline LDH 49 gallium containing 49 Angiox ® 49 tecarfarin 49 CCX# 49 symptomatic intracranial hemorrhage 49 tubulin inhibitor 49 Panzem R NCD 49 Genentech Rituxan 49 VAPRISOL 49 liver histology 49 hematological tumors 49 5 HT2C receptor 49 MoxDuo ® 49 Oral Insulin 49 hepatocellular carcinomas 49 Renal Cell Carcinoma RCC 49 DEB# 49 PSADT 49 QuadraSphere 49 c myc gene 49 pancreatic adenocarcinoma 49 fenofibric acid 49 Chemetics R 49 p# Shc 49 ularitide 49 adjuvant radiotherapy 49 Inhibin 49 Zemplar Capsules 49 intensity allogeneic stem 49 atacicept 49 grade cervical dysplasia 49 glucagon receptor 49 platelet inhibitor 49 metastatic RCC 49 mutated K ras 49 DNA methylation markers 49 ß amyloid 49 CRMD# 49 Actelion Tracleer 49 immunofluorescence staining 49 ganaxolone 49 Activity Assay 49 Alferon N 49 Zenpep 49 Solasia 49 EG# [001] 49 endothelial progenitor cell 49 myeloproliferative disorders 49 ProSavin 49 PI3 kinase inhibitors 49 Familial hypercholesterolemia 49 BrachySil ™ 49 Fulvestrant 49 Posaconazole 49 midkine 49 Scil Proteins 49 Gilead Viread 49 Vertex hepatitis C 49 Morphosys 49 PathFinderTG 49 Septin9 49 NuroPro ® 49 foveal thickness 49 urothelial carcinoma 49 hematological parameters 49 NeuroSolutions 49 EHT Dx# 49 ZFP 49 nodal metastasis 49 BENICAR 49 Surfactant Replacement Therapy 49 mRCC 49 cardiac contractility 49 kinase inhibition 49 MAXY alpha 49 TLR9 agonist 49 Surgical resection 49 BRILINTA 49 cancerous colon polyps 49 amaZon 49 Glybera 49 pharmacological chaperone 49 SNT MC# 49 DU #b 49 favorable tolerability 49 Gemzar gemcitabine 49 Proellex TM 49 hematological malignancy 49 DPX Survivac 49 Solaraze 49 CAPHOSOL 49 antiapoptotic 49 human microdosing 49 pegylated liposomal doxorubicin PLD 49 prostatic tissue 49 clonidine hydrochloride 49 MEND CABG II 49 hsCRP levels 49 IL 1ß 49 Chipscreen 49 radiation dosimetry 49 commented Alexis Borisy 49 JAK2 inhibitors 49 LungAlert TM 49 dutogliptin 49 aldosterone hormone 49 Boceprevir 49 dose melphalan 49 HOMA IR 49 CCR2 49 MYLOTARG 49 viral kinetics 49 chemosensitivity 49 LungExpress Dx TM 49 Zemplar 49 Removab 49 StemEx R 49 Thorough QT 49 malignant pleural mesothelioma 49 CINOD 49 debulking surgery 49 Ventavis ® 49 oral treprostinil 49 outlicensing 49 Xerecept 49 novel histone deacetylase 49 Solorel TM 49 CINtec ® PLUS 49 clot retrieval 49 pediatric acute lymphoblastic 49 Oncaspar 49 DNA methylation biomarkers 49 HuMax EGFr 49 T1c 49 HuMax CD4 49 StemEx 49 serum calcium levels 49 confirmatory clinical 49 difluprednate 49 danoprevir 49 mGluR5 inhibition 49 Perclose 49 cardioprotective effects 49 QTinno TM 48 EDEMA3 48 Urocidin ™ 48 angiographic restenosis 48 serotonin synthesis 48 TLE3 48 vinorelbine tartrate 48 HIV coinfected 48 extracapsular extension 48 MGMT methylation 48 ACZ# 48 DACH platinum 48 Hedgehog inhibitor 48 microRNA profiling 48 dose escalation Phase 48 PGxPredict 48 Soft Tissue Sarcoma 48 MIST II 48 revascularized 48 advanced hepatocellular carcinoma 48 Hsp# inhibition 48 diagnostic prognostic 48 Intarcia 48 SERCA2a 48 cytokine refractory 48 BeneFIX 48 antiandrogen 48 USL# 48 K DOQI guidelines 48 PROCHYMAL 48 mg/m2 cohort 48 NeuroDiscovery 48 Phospha E 48 binary restenosis 48 Vectibix panitumumab 48 selectively inhibited 48 VITAL Trial 48 Provecta 48 HGS ETR2 48 Elan NanoCrystal 48 XL# SAR# 48 SLx 48 Exelixis XL# 48 nanomolar potency 48 sorafenib Nexavar ® 48 Merck Isentress 48 ruxolitinib 48 A3 adenosine receptor 48 LentiVector 48 Capsulution 48 HER2 expression 48 prognostic indicators 48 Santaris 48 statistically significant efficacy 48 heparins 48 hemangioblast 48 HuCAL antibodies 48 Wellstat 48 radiolabeled 48 LV dysfunction 48 Phase #/#a clinical 48 hA# 48 basal cell carcinoma BCC 48 Bayer Onyx 48 adenoma detection 48 Protelos 48 obstructive coronary artery 48 Multiple Ascending Dose 48 Firazyr 48 Platinum Chromium 48 peak plasma concentrations 48 breast carcinomas 48 mL/min/#.# m 2 48 alpha7 NNR 48 Paromomycin 48 Infinium assay 48 GAMMAGARD 48 elvucitabine 48 Technosphere Insulin 48 COBAS R 48 CellMed 48 tumors GIST 48 Valsartan 48 Bioequivalence 48 ADVIA 48 PROactive study 48 PREVU 48 taxane therapy 48 metabolite concentrations 48 lesional 48 Revascor ™ 48 ADAGIO study 48 microdose 48 hematologic parameters 48 mTOR inhibitors 48 Adaptive Radiation Therapy 48 histologically confirmed 48 Dextofisopam 48 PROMUS 48 Taxol ® 48 velafermin 48 LungSign TM 48 somatostatin analogues 48 OnDose 48 hepatic fat 48 LH RH 48 BrachySil 48 Ganciclovir 48 novel mTOR inhibitor 48 quinapril 48 NNRTI resistant virus 48 hepatocellular cancer 48 ImmuneY2 48 aldehyde dehydrogenase ALDH2 deficiency 48 immunomodulatory therapy 48 Bosutinib 48 anti angiogenic therapy 48 fludarabine cyclophosphamide 48 Anticalin 48 drug eluting coronary stent 48 Isis Pharma 48 intravascular hemolysis 48 Targretin capsules 48 LabCorp LH 48 pioglitazone hydrochloride 48 boosted atazanavir 48 IgG1 antibody 48 genotypic resistance 48 Simulect 48 Evoltra 48 PN# [001] 48 novel nucleoside analog 48 CTx 48 SurroMed 48 fibrosis progression 48 intestinal mucosal 48 RNA antagonists 48 BIIR 48 Nexeon 48 Adenoscan 48 theranostic 48 PEP# [003] 48 LV ejection fraction 48 Eraxis 48 serotonin reuptake inhibition 48 pancreatic islet cell 48 gastric adenocarcinoma 48 biomarker assays 48 completely resected 48 MammaPrint ® 48 Trofile assay 48 oblimersen 48 laparoscopic radical nephrectomy 48 HERmark assay 48 Akzo Nobel Organon 48 Dainippon Pharmaceutical 48 HDL LDL ratio 48 HDL Mimetic Peptide 48 P2V TM 48 guaiac 48 Aurora kinase inhibitor 48 Serum creatinine 48 molecular diagnostic assay 48 drug eluting stent DES 48 relapsed ALL 48 PLX STROKE targeting 48 InterfeRx 47 triglyceride concentrations 47 BNC# 47 MMSE score 47 menstrual stem cell 47 Genzyme Isis 47 glatiramer acetate Copaxone 47 fluorescence endoscopy 47 Schering Pharma 47 RenalGuard System TM 47 Aestus 47 glioblastoma tumors 47 PTX 47 Modrenal 47 XL# XL# 47 Cypher Stent 47 antiviral potency 47 phase IIa clinical 47 teriflunomide 47 selective agonists 47 RAS mutations 47 Combination therapy 47 Akt inhibitor 47 NMP# BladderChek 47 myelofibrosis polycythemia vera 47 Erbitux cetuximab 47 Enhanze Technology 47 CALGB 47 ERK activation 47 PD2i Analyzer 47 Xience Prime 47 cardioprotection 47 AsepticSure 47 MoxDuo 47 QVAR 47 convenient dosing regimens 47 perioperative morbidity 47 postoperative mortality 47 intact parathyroid hormone 47 radiolabeling 47 PDE7B 47 mesylate 47 TGR5 47 periprocedural MI 47 Aprovel 47 molecular diagnostic assays 47 PLAVIX ® 47 NovoNordisk 47 Orqis Medical 47 Q#IR 47 fructosamine 47 PROSTVAC ® 47 enoximone 47 Apitope 47 Vysis 47 olmesartan medoxomil hydrochlorothiazide 47 ABILIFY ® 47 Phase 1b trial 47 histological subtype 47 Coronary stent 47 ASCT 47 RX ACCULINK 47 SURFAXIN r 47 assessing T DM1 47 metastatic gastric 47 rhFVIIa 47 OrCel 47 acromegalic patients 47 Zyprexa olanzapine 47 rotary VAD 47 antithrombotic therapies 47 dopamine D2 receptor 47 reteplase 47 BEXXAR 47 Kevetrin ™ 47 neurocognitive deficits 47 glycoprotein GP IIb IIIa 47 Preclinical studies 47 Harry Palmin President 47 polyp detection 47 Central Venous Catheter 47 3 kinase PI3K 47 Oncimmune 47 V3D Colon 47 microvessel density 47 neoadjuvant treatment 47 histone deacetylase HDAC 47 effector functions 47 oral fludarabine 47 multimodality therapy 47 chromosome #p# [002] 47 CellPort Technologies 47 oxidative stress inducer 47 Cimzia TM 47 prolactin elevation 47 Nascobal Nasal Spray 47 pulmonary exacerbations 47 BLA filing 47 DAPT 47 PSA nadir 47 Belatacept 47 selectively binds 47 VEGF expression 47 Carvedilol 47 CVD mortality 47 nonmetastatic 47 mucosal healing 47 Pfizer Selzentry 47 neuroprotective properties 47 ClearPath TM 47 BRAF inhibitors 47 calcium antagonists 47 fluorescence polarization 47 HTRF 47 Sonatherm 47 EOquin 47 antiviral efficacy 47 Lamotrigine 47 GENASIS trial 47 myelodysplastic syndrome MDS 47 renal cysts 47 Phase III confirmatory 47 inhalation aerosol 47 GEMS TM 47 GAP #B# 47 CIP TRAMADOL ER 47 tipranavir r 47 periodontal tissues 47 Myoblast Program 47 Aureon 47 prasugrel Effient 47 BCR ABL inhibitors 47 capillary leakage 47 affinity purification 47 Prima BioMed 47 Microarray analysis 47 symptomatic paroxysmal AF 47 pharmacokinetic pharmacodynamic 47 retaspimycin 47 TR FRET 47 SuperAntibody 47 antibody humanization 47 TAXUS Stent 47 Metricath Gemini 47 orally disintegrating 47 Nucleic Acid Test 47 radiolabelled 47 oral ridaforolimus 47 antiangiogenic activity 47 refractory colorectal cancer 47 RE COVER 47 MetMAb 47 Microdosing 47 Ixempra 47 Celsentri Selzentry 47 maximally tolerated 47 MET amplification 47 Tracleer R 47 antihypertensive therapies 47 Insulin PH# 47 R0 resection 47 coexpression 47 INT# [002] 47 Abeta# 47 contractile function 47 albumin excretion 47 TransVax tm 47 IIIA NSCLC 47 renal cell carcinomas 47 Fenofibrate 47 SensiGene 47 Oncolys 47 COR Analyzer 47 serum triglycerides 47 HYLENEX recombinant 47 olmesartan medoxomil 47 norepinephrine reuptake inhibition 47 Shire BioChem Inc. 47 pharmacokinetic PK profile 47 Tekmira SNALP technology 47 shorter telomere length 47 ASONEP 47 AQUA ® 47 CryoMaze 47 Nitec 47 plasma triglycerides 47 Altrazeal R 47 Raf MEK ERK 47 Rituxan rituximab 47 serum urate levels 47 Zavesca r 47 Wyeth Enbrel 47 bortezomib Velcade R 47 xTAG 47 Magnesium deficiency 47 Phase Ib IIa clinical 47 muscarinic antagonist 47 non resectable 47 ProSanos 46 mutated KRAS 46 Cardioxyl 46 Drug eluting stent 46 exogenous insulin 46 RAPAFLO 46 SoftScan ® 46 haematopoietic stem cell 46 blood glucose concentrations 46 SANVAR 46 casopitant 46 FBPase 46 TOF TOF 46 TM Everolimus Eluting 46 TLR agonists 46 CDI recurrence 46 Micromet BiTE 46 neutrophil counts 46 eXplore Optix 46 rechallenge 46 rilpivirine 46 Arixtra 46 Rottapharm Madaus 46 Multidetector CT 46 tipranavir 46 Pharmacokinetic parameters 46 Miracor 46 Urocidin 46 Imprime PGG ® 46 metastatic bladder 46 radiographic outcomes 46 bronchoscopic 46 DF HCC 46 aminotransferases 46 Thal Dex 46 Zavesca ® 46 dietary carbohydrate 46 RBP4 levels 46 Cinacalcet HCl 46 ER CHOP 46 B. Lynne Parshall 46 IL #E 46 eTag assays 46 Perindopril 46 Dalbavancin 46 Verigene System 46 sd rxRNA 46 Roche Chugai 46 favorable pharmacokinetic profile 46 IMC #F# 46 ELACYT 46 NanoCrystal technology 46 opioid analgesia 46 vascular stent